Pfizer says antiviral pill cuts risk of severe Covid-19 by 89%
The results appear to surpass those seen with Merck & Co Inc's pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for Covid-19 patients also at high risk of serious illness.
Post a Comment